Dalton Pharma Services And Myelin Repair Foundation Enter into Chemistry Collaboration

Published: Oct 22, 2008

SARATOGA, Calif. & TORONTO--(BUSINESS WIRE)--The Myelin Repair Foundation and Dalton Pharma Services jointly announce a chemistry collaboration to develop new potential therapeutic compounds for myelin degradation disease states such as Multiple Sclerosis (MS).

Back to news